Skip to Content


In the US, Alefacept (alefacept systemic) is a member of the drug class selective immunosuppressants and is used to treat Plaque Psoriasis and Psoriasis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Selective immunosuppressant


Chemical Name

1-92-antigen LFA-3 (human) fusion protein wit human immunoglobulin G1 (hinge-CH2-CH3 gamma1-chain), dimer (WHO)

Foreign Names

  • Alefaceptum (Latin)
  • Alefacept (German)
  • AlĂ©facept (French)
  • Alefacept (Spanish)

Generic Names

  • Alefacept (OS: USAN, BAN)
  • BG 9273 (IS: Biogen)
  • BG 9712 (IS: Biogen)
  • Human LFA 3IgG fusion protein (IS)
  • Leukocyte function-associated antigen-3 (IS)
  • LFA 3 (IS)
  • LFA 3CD2 (IS)
  • LFA 3TIP (IS: Biogen)
  • LFA-(92)IgG (IS)
  • Recombinant LFA-3/IgG1 fusion protein (IS)

Brand Name


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.